Perspectives on Ligand/Protein Binding Kinetics Simulations: Force Fields, Machine Learning, Sampling, and User-Friendliness
- PMID: 37656199
- PMCID: PMC10536999
- DOI: 10.1021/acs.jctc.3c00641
Perspectives on Ligand/Protein Binding Kinetics Simulations: Force Fields, Machine Learning, Sampling, and User-Friendliness
Abstract
Computational techniques applied to drug discovery have gained considerable popularity for their ability to filter potentially active drugs from inactive ones, reducing the time scale and costs of preclinical investigations. The main focus of these studies has historically been the search for compounds endowed with high affinity for a specific molecular target to ensure the formation of stable and long-lasting complexes. Recent evidence has also correlated the in vivo drug efficacy with its binding kinetics, thus opening new fascinating scenarios for ligand/protein binding kinetic simulations in drug discovery. The present article examines the state of the art in the field, providing a brief summary of the most popular and advanced ligand/protein binding kinetics techniques and evaluating their current limitations and the potential solutions to reach more accurate kinetic models. Particular emphasis is put on the need for a paradigm change in the present methodologies toward ligand and protein parametrization, the force field problem, characterization of the transition states, the sampling issue, and algorithms' performance, user-friendliness, and data openness.
Conflict of interest statement
The authors declare no competing financial interest.
Figures



Similar articles
-
Machine learning in computational docking.Artif Intell Med. 2015 Mar;63(3):135-52. doi: 10.1016/j.artmed.2015.02.002. Epub 2015 Feb 16. Artif Intell Med. 2015. PMID: 25724101
-
Kinetics of Ligand-Protein Dissociation from All-Atom Simulations: Are We There Yet?Biochemistry. 2019 Jan 22;58(3):156-165. doi: 10.1021/acs.biochem.8b00977. Epub 2018 Dec 28. Biochemistry. 2019. PMID: 30547565 Review.
-
Toward High-Throughput Predictive Modeling of Protein Binding/Unbinding Kinetics.J Chem Inf Model. 2016 Jun 27;56(6):1164-74. doi: 10.1021/acs.jcim.5b00632. Epub 2016 May 20. J Chem Inf Model. 2016. PMID: 27159844 Free PMC article.
-
Relative Binding Free Energy Calculations in Drug Discovery: Recent Advances and Practical Considerations.J Chem Inf Model. 2017 Dec 26;57(12):2911-2937. doi: 10.1021/acs.jcim.7b00564. Epub 2017 Dec 15. J Chem Inf Model. 2017. PMID: 29243483
-
Dynamic Docking: A Paradigm Shift in Computational Drug Discovery.Molecules. 2017 Nov 22;22(11):2029. doi: 10.3390/molecules22112029. Molecules. 2017. PMID: 29165360 Free PMC article. Review.
Cited by
-
Prediction of enzyme inhibition (IC50) using a combination of protein-ligand docking and semiempirical quantum mechanics.J Mol Model. 2025 Jul 12;31(8):209. doi: 10.1007/s00894-025-06423-7. J Mol Model. 2025. PMID: 40650762 Free PMC article.
-
Computational screening of the effects of mutations on protein-protein off-rates and dissociation mechanisms by τRAMD.Commun Biol. 2024 Sep 17;7(1):1159. doi: 10.1038/s42003-024-06880-5. Commun Biol. 2024. PMID: 39289580 Free PMC article.
-
Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery.Nat Rev Drug Discov. 2025 Apr;24(4):251-275. doi: 10.1038/s41573-024-01083-3. Epub 2025 Jan 2. Nat Rev Drug Discov. 2025. PMID: 39747671 Review.
-
Investigating the unbinding mechanisms and kinetics of MmpL3 inhibitors: A computational study.Protein Sci. 2025 Jun;34(6):e70163. doi: 10.1002/pro.70163. Protein Sci. 2025. PMID: 40371723
-
The Open Force Field Initiative: Open Software and Open Science for Molecular Modeling.J Phys Chem B. 2024 Jul 25;128(29):7043-7067. doi: 10.1021/acs.jpcb.4c01558. Epub 2024 Jul 11. J Phys Chem B. 2024. PMID: 38989715 Free PMC article.
References
-
- Mullard A. New drugs cost US$2.6 billion to develop. Nat. Rev. Drug Discovery 2014, 13, 877.10.1038/nrd4507. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources